Thursday, April 17, 2014. Last Update: Wed 3:22 PM EST

The Second Opinion

ocareshadow.jpg

Obamacare? I wasn’t aware…

A takeaway for reporters from the latest Kaiser poll numbers: don’t forget who the law is for

When it comes to summarizing the key findings of the latest Kaiser Health Tracking Poll, this Washington Post headline neatly... More

hasselbeck.jpg

Fox News, so confused?

Fox & Friends does nothing to clarify one woman’s confusing Obamacare trials, but still gets its message across

By now, we're accustomed to tales from the Obamacare trenches--good, bad, and ugly--spun in the media. There was Deborah Cavallaro,... More

seniorspay.jpg

Will seniors pay the price?

The hospital lobby’s agenda is clear—hit up Medicare beneficiaries, not hospitals, to pay for the “doctor fix”—and merits wider coverage

A telephone call with reporters on January 23 couldn't have been more explicit. The American Hospital Association, the big trade... More

healthID.jpg

Got health coverage? Prove it!

How widespread are proof-of-coverage problems? Fort Myers News-Press took an extra step to find out.

If insurance exchange shoppers thought their trials would necessarily end once they were--finally--able to log on and do the hard... More

obamacare.jpg

How to measure Obamacare success

It’s too soon to pass judgment. But reporters can keep the debate honest and focused on the law’s core goal

A woman I'll call Gina, a 58-year-old hairdresser and Manhattan resident, is one of more than 587,000 New Yorkers who... More

laurelrevisedhomepage.png

OC Register explodes Medicare myths

A laurel to the paper’s deep dive into Medicare Part D showing “profit trumps public interest”

As the Affordable Care Act tumbled along its rocky path to implementation, the media drew parallels between its disastrous... More

medicalbill.jpg

Wonkblog on the ACA cost-control feature that might make you change your doctor

Sarah Kliff explores why wonks love “narrow networks,” and why consumers might hate them

Score one for Sarah Kliff's Health Reform Watch column this week. Her Monday Q-and-A at WaPo's Wonkblog offered a clear,... More

ocareanecdote.jpg

Warning: This anecdote may be harmful to your story’s health

Six questions to ask before using an Obamacare tale

Healthcare-related media criticism doesn't often go viral, or even semi-viral, but the writer Maggie Mahar scored big earlier this month... More

laurelrevisedhomepage.png

A laurel for the Journal Sentinel

For five years, John Fauber has done standout reporting on the medical establishment’s unsavory business dealings

Those who say watchdog journalism is dead and gone are just plain wrong. And there's no better way to... More

DrugManufacturing.jpg

The new hepatitis C drug costs how much?!

NPR’s Richard Knox gets its right the second time around on high pharmaceutical prices

When the Food and Drug Administration in early December approved sofosbuvir, an important new drug to treat hepatitis C, most... More

medicalbill.jpg

The Great Cost Shift comes into focus

It’s time for the press to lead a conversation about who bears healthcare costs

As the tumultuous year of the Affordable Care Act comes to an end, one of the central storylines of health... More

SteveBrill.jpg

Brill is back, and other ACA shout-outs

Kudos to good work in Time and The New York Times

From time to time this space will offer a roundup of interesting, well-done, and useful stories about healthcare and health... More

docback.jpg

Exchange Watch: Missing doctors, missing coverage

In New York, insurance exchange shoppers (if not enough reporters) discover the lack of out-of-network benefits

At the tail end of October, when the media were hyper-fixated on the woes of HealthCare.gov and who knew what... More

medicalbill.jpg

Better late than never: the new insurance sticker shock story

The press discovers high cost sharing, but the story goes deeper

As coverage of the Affordable Care Act rolls along, the pesky subject of high out-of-pocket costs for plans purchased on... More

dollarsigns.jpg

Did the gee-whiz drug story make a comeback?

NPR’s piece on a new hepatitis C med fell short on costs, conflicts, and caveats

To hear NPR's piece last week about the FDA's then-imminent approval of a new drug to treat hepatitis C--sofosbuvir, approved... More

It doesn’t add up - A science writer questions the conventional wisdom of US-born STEM workers

#Realtalk: Dear reader - For small sites, loyalty might be a better path to pageviews

Falling for internet hoaxes - Some people who share satire don’t realize they’re missing the punchline

Digital First plans layoffs (Updated) - High-level executives and high-profile digital projects targeted

Nobody’s that lucky’—except in Florida’s lottery? - Palm Beach Post ferrets out lottery fraud, prompts tightening of “meager” safeguards


The future of Facebook may not say ‘Facebook’

The future of the social network is apps—lots and lots of apps

Bitcoin creator ‘Satoshi Nakamoto’ unmasked-again?

A linguistics analysis suggests that Nick Szabo, a well known name in cryptography circles, is the mysterious father of the digital currency

The Center for Public Integrity’s response to ABC News

“I urge you to go to your reporters and engage in serious self-examination”

The slaughter bench of history

How war has made the world safer and richer

New Jersey’s good government

Despite the bridge scandal, Chris Christie’s state is relatively transparent and accountable. CJR’s Greg Marx talks to Gordon Witkin

  • If you like the magazine, get the rest of the year for just $19.95 (6 issues in all).
  • If not, simply write cancel on the bill and return it. You will owe nothing.

Who Owns What

The Business of Digital Journalism

A report from the Columbia University Graduate School of Journalism

Study Guides

Questions and exercises for journalism students.